Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2021-02-12 4:30 pm Purchase | 13G | CHINOOK THERAPEUTICS INC KDNY | Vivo Capital IX LLC | 987,624 2.3% | 987,624 (New Position) | View |
2021-02-12 4:30 pm Sale | 13G | MATINAS BIOPHARMA HLDGS INC CO MTNB | Vivo Capital IX LLC | 5,274,638 2.6% | -5,002,825 (-48.68%) | View |
2021-02-12 4:30 pm Purchase | 13G | ESSA PHARMA INC EPIX | Vivo Capital IX LLC | 1,562,603 4.7% | 152,089 (+10.78%) | View |
2021-02-12 4:30 pm Unchanged | 13G | Trillium Therapeutics Inc. TRIL | Vivo Capital IX LLC | 0 0% | 0 (Unchanged) | View |
2020-11-06 4:31 pm Purchase | 13G | ESSA PHARMA INC EPIX | Vivo Capital IX LLC | 1,410,514 4.4% | 1,410,514 (New Position) | View |
2020-10-28 4:31 pm Purchase | 13G | TARSUS PHARMACEUTICALS INC TARS | Vivo Capital IX LLC | 3,245,035 16.2% | 3,245,035 (New Position) | View |
2020-07-29 4:35 pm Purchase | 13G | ALX ONCOLOGY HLDGS INC ALXO | Vivo Capital IX LLC | 4,034,522 11.1% | 4,034,522 (New Position) | View |
2020-07-10 4:30 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Vivo Capital IX LLC | 30,595,624 9% | 16,480,873 (+116.76%) | View |
2020-06-30 4:30 pm Purchase | 13G | GENETRON HOLDINGS LIMITED ADS GTH | Vivo Capital IX LLC | 28,574,300 6.5% | 28,574,300 (New Position) | View |
2020-06-26 4:31 pm Sale | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | Vivo Capital IX LLC | 1,369,863 1.6% | -5,102,560 (-78.84%) | View |
2020-06-26 4:31 pm Purchase | 13G | IVERIC BIO INC ISEE | Vivo Capital IX LLC | 4,878,048 5.8% | 4,878,048 (New Position) | View |
2020-06-12 5:00 pm Purchase | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Vivo Capital IX LLC | 14,114,751 6.6% | 14,114,751 (New Position) | View |
2020-06-11 5:27 pm Purchase | 13G | ADURO BIOTECH, INC ADRO | Vivo Capital IX LLC | 4,184,776 5.2% | 4,184,776 (New Position) | View |
2020-06-11 5:07 pm Purchase | 13G | LARIMAR THERAPEUTICS INC LRMR | Vivo Capital IX LLC | 653,779 4.3% | 653,779 (New Position) | View |
2020-02-13 4:30 pm Purchase | 13G | CHIASMA INC CHMA | Vivo Capital IX LLC | 1,064,226 2.5% | 1,064,226 (New Position) | View |
2020-02-13 4:30 pm Purchase | 13G | MATINAS BIOPHARMA HLDGS INC CO MTNB | Vivo Capital IX LLC | 10,277,463 5.3% | 10,277,463 (New Position) | View |
2020-02-13 4:30 pm Purchase | 13G | SIERRA ONCOLOGY INC SRRA | Vivo Capital IX LLC | 1,455,576 14% | 1,455,576 (New Position) | View |
2020-02-03 4:03 pm Purchase | 13G | TRILLIUM THERAPEUTICS INC SCTPF | Vivo Capital IX LLC | 3,679,060 4.9% | 3,679,060 (New Position) | View |
2019-12-30 4:20 pm Purchase | 13G | CARTESIAN THERAPEUTICS, INC. C RNAC | Vivo Capital IX LLC | 6,472,423 7.5% | 6,472,423 (New Position) | View |